In studies using APP/PS1 transgenic mice, GJ-4 was demonstrated to ameliorate cognitive impairments by preventing neuroinflammation through the PI3K/Akt pathway (Zang et al., 2021). This evidence concerns the gene AKT1 and Cognitive impairment.